FIGURE 3.

Aberrant CD68, CD86 and CD163 expression in tumours illustrates the prognosis in colorectal cancer patients for RFS. A. Kaplan‐Meier survival curves showed RFS in 64 patients. B. High CD68 expression is not associated with overall survival in CRC patients. C‐D. High expression of CD86 and low expression of CD163 are associated with favourable prognosis in human colorectal cancer samples. E. High co‐expression of CD68 and CD86 is associated with favourable prognosis. F. High co‐expression of CD68 and CD163 is associated with poor prognosis in CRC. The P‐value was obtained using the log‐rank test of the differences